Medical condition
Tnbc
Tnbc is a medical condition tracked by NovaPharmaNews across 3 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- atezolizumab (TECENTRIQ) Antineoplastic and immunomodulating agents (L01)
- pembrolizumab (KEYTRUDA) Antineoplastic and immunomodulating agents (L01)
- sacituzumab govitecan (TRODELVY) Antineoplastic and immunomodulating agents (L01)
